Studying the Effect of Cholesterol and Activin a Hormone on Inducing Abortion in Pregnant Women

Noor Hasan Ahmed

doi:10.55544/jrasb.3.2.32

Authors

Noor Hasan Ahmed Department of Biology, College of Sciences, University of Tikrit, IRAQ.

DOI:

https://doi.org/10.55544/jrasb.3.2.32

Keywords:

abortion, cholesterol, activin hormone

Abstract

The current study aimed to show the relationship between the levels of (activin-A hormone) and the concentration of lipids cholesterol) and the occurrence of some cases of Abortion and threatened pregnancy The study included 150 blood samples taken from aborted women and women with a threatened pregnancy, which is diagnosed by ultrasound scan and other methods such as clinical examinations and the history of the pregnant woman. Their ages ranged between (16-45) who visited Tikrit Teaching Hospital and private outpatient clinics. It was divided into three groups: The first included 50 blood samples from aborted women, 20 blood samples from women with a threatened pregnancy, and 20 blood samples from women with normal pregnancies as a control group. Blood samples were taken during the first trimester of pregnancy. The results of this study showed a significant increase in the concentration of (activin-A hormone) at a significant level (P ≤ 0.05) in the aborted women group .And women threatened with abortion compared with the control group, as well as a significant increase in the level of lipids (cholesterol) at a significant level (P ≤ 0.05)in the abortion group and the group of women threatened with abortion compared with the control group.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Magawan, B. (2001). Obstetrics and gunecology. 2nd ed. Churchill Livingstone. Pp: 150-159.

Chamberlain, GV. (1996). Obestetrics by ten teachers, 6th ed., Edward Amold, London .

Wouters, MG.; Boers, GH. and Blom, H. (1993). Hyperhomocysteinemia: arisk factor in women with unexplained recurrent early pregnancy loss. Fertile-steril., 60: 820-825 .

Hill, J.A. (1998). Recurrent pregnancy loss. In: Creasy, R.K. and Resnik, R. (eds), Maternal fetal medicine, 3rd ed. Saunders, philadelphia, pp:423-443.

Vale, W.; Rivier, J and Vaughan, J. (1986). Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature. 321: 776-779 .

Loveland, K.; farlane, JR. and Dekretser, DM. (1996). Expression of activin-B. Subunit messenger RNA in reproductive tissues., J. Molecular Endocrinol. Vol. (17) Pp :61-65 .

Petraglia, F., Sawchenko, P.; Lim, At., Rivier, Jand Vale, W. (1987). Localization, Secretion and action of inhibin in human placenta. Science. 237: 187-189.

Florio, P.; severi, F.M.; cobellis, L.; Danero, S.; Bome, A and Luisi, S. (2002). Serum activin-A and inhibin-A. Newclinical markers for hydatidiform mole. Cancer., 94: 2618-2622.

Tietz, N. W. (1999). Text book of clinical chemistry 3rd Ed C. A. Burtis. ER. Ashwood, W.B. Saunders. P 826-835.

Kirkwood, B.R. (1988). "Medical statistic Black well stientific publications Oxford 1st ed pp:38,89-148 .

Muttukrishna,S.; North, R.A.; Morris, J.; Schellenberg, J.C.; Taylor R.S. Asselin, J.; Ledger, WL. and Redman, C.W .(2000) Serum inhibin-A and Activin-A are elevated prior to the onset of pre-eclampsia. Hum. Reprod., 15:1640-1645 .

Muttu Krishna, S.; child, TJ.; Groome, NP. and Ledger, WL. (1997). Source of circulating levels of inhibin-A, pro-alpha C-containing inhibins and activin- A in early pregnancy. Human Reproduction Journal. Oxford University. Vol., (12). Pp: 1089-1093.

Florio, P.; Luisi, S.; Ciarmela, P.; Severi, FM.; Bocchi, C. and petraglia, F. (2004). Inhibins and activins in pregnancy. Mol. Cell Endocrinol., 225 (1-2):93-100 .

Florio, P.; severi, F.M.; cobellis, L.; Danero, S.; Bome, A and Luisi, S. (2002). Serum activin-A and inhibin-A. Newclinical markers for hydatidiform mole. Cancer., 94: 2618-2622.

Blackburn.C.A. Keelan JA.; Taylor, R.S.; North, R.A.(2003) Maternal serum activin-A is not elevated before preeclampsia in women who are at high risk.AM.J. Obstet Gynecol.188:807-811.

Eramaa, M.; Heikinheimo; K.; Tuuri, T.; Hilden, K. and Ritvos, O. (1993). Inhibin/Activin Subunit mRNA expression in human granulose luteal cells. Mol. Cell. Endocrinology., 92, R15-R20

Butte, N. F., Wong, W. W., Hopkinson, J. M., Heinz, C. J., Mehta, N. R., & Smith, E. O. B. (2000). Energy requirements derived from total energy expenditure and energy deposition during the first 2 y of life. The American journal of clinical nutrition, 72(6), 1558-1569.

Tietz, N. W. (1999). Text book of clinical chemistry 3rd Ed C. A. Burtis, ER. Ashwood, WB. Saunders. P 826-835.

Vander, V.; Sherman, J. and Lucan D. (1998) Human physiology.7th ed. McGraw-Hill, Newyork.Pp:601-616.